Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rapid beneficial effect of the IL-6 receptor blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis.
Castañeda S, Remuzgo-Martínez S, López-Mejías R, Genre F, Calvo-Alén J, Llorente I, Aurrecoechea E, Ortiz AM, Triguero A, Blanco R, Llorca J, González-Gay MA. Castañeda S, et al. Among authors: llorente i. Clin Exp Rheumatol. 2019 May-Jun;37(3):465-473. Epub 2018 Nov 7. Clin Exp Rheumatol. 2019. PMID: 30418124 Free article.
Anti-IL-6 therapy reduces leptin serum levels in patients with rheumatoid arthritis.
Pulito-Cueto V, Remuzgo-Martínez S, Genre F, Calvo-Alén J, Aurrecoechea E, Llorente I, Triguero-Martinez A, Blanco R, Llorca J, Ruiz-Lucea E, Rivera-García N, Gualillo O, López-Mejías R, Castañeda S, González-Gay MA. Pulito-Cueto V, et al. Among authors: llorente i. Clin Exp Rheumatol. 2020 Nov-Dec;38(6):1201-1205. Epub 2020 May 20. Clin Exp Rheumatol. 2020. PMID: 32452351
Role of adiponectin in non-diabetic patients with rheumatoid arthritis undergoing anti-IL-6 therapy.
Pulito-Cueto V, Remuzgo-Martínez S, Genre F, Calvo-Alén J, Aurrecoechea E, Llorente I, Triguero-Martinez A, Blanco R, Llorca J, Ruiz-Lucea E, Rivera-García N, Gualillo O, López-Mejías R, Castañeda S, González-Gay MA. Pulito-Cueto V, et al. Among authors: llorente i. Clin Exp Rheumatol. 2022 May;40(5):988-992. doi: 10.55563/clinexprheumatol/p8nx80. Epub 2021 Jul 7. Clin Exp Rheumatol. 2022. PMID: 34251326 Free article.
Rituximab induces a lasting, non-cumulative remodelling of the B-cell compartment.
López J, Merino L, Piris L, Herrera FS, Llorente I, Humbría A, Ortiz AM, Velasco T, García-Vicuña R, Castañeda S, González Álvaro I, Muñoz-Calleja C. López J, et al. Among authors: llorente i. Clin Exp Rheumatol. 2019 Jul-Aug;37(4):615-622. Epub 2018 Dec 19. Clin Exp Rheumatol. 2019. PMID: 30620289 Free article.
The presence of both HLA-DRB1*04:01 and HLA-B*15:01 increases the susceptibility to cranial and extracranial giant cell arteritis.
Prieto-Peña D, Remuzgo-Martínez S, Ocejo-Vinyals JG, Atienza-Mateo B, Genre F, Muñoz-Jimenez A, Ortiz-Sanjuán F, Romero-Yuste S, Moriano C, Galindez-Agirregoikoa E, Calvo I, Ortego-Centeno N, Álvarez-Rivas N, Miranda-Filloy JA, Llorente I, García-García J, Blanco R, Gualillo O, Martin J, Castañeda S, Lopez-Mejías R, González-Gay MA. Prieto-Peña D, et al. Among authors: llorente i. Clin Exp Rheumatol. 2021 Mar-Apr;39 Suppl 129(2):21-26. doi: 10.55563/clinexprheumatol/nn15lt. Epub 2021 Mar 18. Clin Exp Rheumatol. 2021. PMID: 33734973 Free article.
Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotype.
Prieto-Peña D, Remuzgo-Martínez S, Genre F, Ocejo-Vinyals JG, Atienza-Mateo B, Muñoz-Jimenez A, Ortiz-Sanjuán F, Romero-Yuste S, Moriano C, Galíndez-Agirregoikoa E, Calvo I, Ortego-Centeno N, Álvarez-Rivas N, Miranda-Filloy JA, Llorente I, Blanco R, Gualillo O, Martín J, Márquez A, Castañeda S, Ferraz-Amaro I, López-Mejías R, González-Gay MA. Prieto-Peña D, et al. Among authors: llorente i. Clin Exp Rheumatol. 2022 May;40(4):727-733. doi: 10.55563/clinexprheumatol/8mku9c. Epub 2022 Mar 23. Clin Exp Rheumatol. 2022. PMID: 35349405 Free article.
Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article "Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis" by Bugatti et al.
Castañeda S, Llorente I, García-Vicuña R, González-Álvaro I. Castañeda S, et al. Among authors: llorente i. Arthritis Res Ther. 2017 Jul 3;19(1):152. doi: 10.1186/s13075-017-1362-5. Arthritis Res Ther. 2017. PMID: 28673340 Free PMC article. No abstract available.
Experience With the Use of Rituximab for the Treatment of Rheumatoid Arthritis in a Tertiary Hospital in Spain: RITAR Study.
Cañamares I, Merino L, López J, Llorente I, García-Vadillo A, Ramirez E, López-Bote JP, Benedí J, Muñoz-Calleja C, Álvaro-Gracia JM, Castañeda S, González-Álvaro I. Cañamares I, et al. Among authors: llorente i. J Clin Rheumatol. 2019 Sep;25(6):258-263. doi: 10.1097/RHU.0000000000000845. J Clin Rheumatol. 2019. PMID: 30001257 Free PMC article.
Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons.
Llorente I, García-Castañeda N, Valero C, González-Álvaro I, Castañeda S. Llorente I, et al. Front Med (Lausanne). 2020 Nov 23;7:601618. doi: 10.3389/fmed.2020.601618. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33330566 Free PMC article. Review.
98 results